Gene Editing, “Cultural Harms,” and Oversight Mechanisms
By Erik Parens,
Bioethics Forum
| 05. 04. 2017
Is it reasonable to hope that concerns about “cultural harms” can be integrated into oversight mechanisms for technologies like gene editing? That question was raised anew for me by the recent National Academy of Sciences report on human genome editing and at a recent conference at Harvard on the international governance of genome editing technologies. I’m somewhat disheartened to be thinking that the answer might be no.
Before explaining how I ended up in what is, for me, a disheartening place, I should clarify what I take the authors of the NAS report to mean by the term “cultural harms.” First, they were not emphasizing that concerns about emerging technologies can vary from culture to culture or from nation to nation. They weren’t talking about how, say, Samoans and Singaporeans hold different values, and about how such differences might make international governance difficult.
They were using “cultural harms” in contradistinction to what we might call “physical harms.” When we worry about physical harms we worry that a technology is going to fail at achieving some near-term purpose we take to...
Related Articles
By Emma McDonald Kennedy
| 07.11.2024
Louise Perry’s recent article in The Spectator cautions against “The quiet return of eugenics,” a threat she locates in preimplantation genetic testing for polygenic disorders. The technology is billed as a way for parents undergoing IVF to select which embryo to implant based on information about each embryo’s genetic risk factors and traits. These reports, she says, give parents “a very full picture of the adult that embryo could become”––from their child’s risk of developing different diseases to their “likely...
GATTACA was released in 1997, but — remarkably — is even more relevant now than it was then, as the technologies whose social implications it explores have developed considerably.
On Thursday, June 13, the California Film Institute presented GATTACA to a sold-out house at the Christopher B. Smith Rafael Film Center as part of their Science on Screen series. CGS Associate Director Katie Hasson offered framing for the film and participated in a Q+A discussion.
The film’s plot explicitly involves...
By Ellie Kincaid, Retraction Watch | 06.18.2024
Nature has retracted a 2002 paper from the lab of Catherine Verfaillie purporting to show a type of adult stem cell could, under certain circumstances, “contribute to most, if not all, somatic cell types.”
The retracted article, “Pluripotency of...